NEW YORK, March 12, 2012 /PRNewswire/ -- Bernstein
Liebhard LLP is investigating whether the Board of Directors of
ZOLL Medical Corporation ("ZOLL" or the "Company") (NASDAQ GS:
ZOLL) breached its fiduciary duty to its shareholders in agreeing
to sell ZOLL to Asahi Kasei Corporation.
(Logo:
http://photos.prnewswire.com/prnh/20120202/MM47134LOGO)
Under the terms of the agreement, ZOLL shareholders will receive
$93 in cash for each share they
own. The investigation is focused on the potential unfairness
of the price to ZOLL shareholders and the process by which the ZOLL
Board of Directors considered and approved the transaction.
If you are interested in discussing your rights as a ZOLL
stockholder, with no obligation or cost to you, please contact
U. Seth Ottensoser at:
(877) 779-1414
or
Ottensoser@bernlieb.com.
Bernstein Liebhard has pursued hundreds of securities, consumer
and shareholder rights cases and recovered over $3 billion for its clients. It has been
named to The National Law Journal's "Plaintiffs' Hot List"
in each of the last nine years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414
www.bernlieb.com
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The
law firm responsible for this advertisement is Bernstein Liebhard
LLP, 10 East 40th Street, New York, New
York 10016, (212) 779-1414. The lawyer responsible for
this advertisement in the State of
Connecticut is Michael S. Bigin. Prior results do not
guarantee or predict a similar outcome with respect to any future
matter.
SOURCE Bernstein Liebhard LLP
